Robert P Giugliano Selected Research

Robert P Giugliano Research Topics

Disease

130	Myocardial Infarction 03/2022 - 06/2002
97	Atrial Fibrillation 09/2022 - 10/2010
94	Stroke (Strokes) 09/2022 - 04/2005
89	Hemorrhage 09/2022 - 04/2003
72	Acute Coronary Syndrome 01/2022 - 01/2003
46	ST Elevation Myocardial Infarction 01/2022 - 07/2002
41	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 06/2002
33	Embolism (Embolus) 09/2022 - 10/2010
21	Unstable Angina 03/2022 - 06/2002
20	Ischemic Stroke 12/2021 - 07/2011
16	Thrombosis (Thrombus) 11/2019 - 12/2004
15	Heart Failure 01/2022 - 12/2002
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2005
12	Infarction (Infarctions) 01/2022 - 09/2003
12	Diabetes Mellitus 01/2021 - 08/2013
12	Ischemia 01/2018 - 02/2004
11	Hemorrhagic Stroke 01/2021 - 09/2011
10	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2008
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2021 - 04/2003
9	Thromboembolism 01/2019 - 10/2010
8	Hypercholesterolemia 07/2022 - 06/2011
8	Atherosclerosis 03/2022 - 10/2010
8	Hypertension (High Blood Pressure) 01/2022 - 02/2005
8	Venous Thromboembolism 01/2020 - 09/2011
7	Body Weight (Weight, Body) 01/2022 - 05/2009
7	Non-ST Elevated Myocardial Infarction 01/2022 - 06/2002
6	Peripheral Arterial Disease 09/2022 - 03/2016
6	Neoplasms (Cancer) 01/2022 - 01/2017
5	Transient Ischemic Attack 11/2020 - 08/2014
4	Reperfusion Injury 04/2016 - 11/2009
3	Aortic Valve Stenosis (Aortic Stenosis) 09/2020 - 03/2017
3	Renal Insufficiency (Renal Failure) 01/2020 - 05/2008
3	Heart Valve Diseases (Valvular Heart Disease) 01/2018 - 03/2017
3	Obesity 08/2014 - 12/2012

Drug/Important Bio-Agent (IBA)

79	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 11/2009
56	edoxabanIBA 09/2022 - 10/2010
53	AnticoagulantsIBA 02/2022 - 06/2007
42	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 09/2008
38	LDL CholesterolIBA 01/2022 - 09/2008
35	evolocumabIBA 07/2022 - 01/2012
35	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 10/2010
30	oxidized low density lipoproteinIBA 07/2022 - 09/2008
28	Vitamin K FDA Link 02/2022 - 10/2010
25	Glycoproteins (Glycoprotein)IBA 01/2020 - 02/2004
22	Ezetimibe (Zetia)FDA Link 01/2022 - 08/2014
19	Eptifibatide (Integrilin)FDA Link 04/2017 - 04/2003
15	LipidsIBA 03/2022 - 09/2008
15	Simvastatin (Zocor)FDA LinkGeneric 10/2021 - 11/2008
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2006
14	Pharmaceutical PreparationsIBA 11/2020 - 06/2003
13	CreatinineIBA 01/2022 - 12/2002
13	Clopidogrel (Plavix)FDA Link 01/2022 - 07/2006
13	Simvastatin Drug Combination Ezetimibe (Vytorin)FDA Link 10/2021 - 11/2008
12	Factor Xa InhibitorsIBA 03/2019 - 10/2010
11	Proprotein Convertase 9IBA 01/2022 - 08/2013
11	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 06/2002
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2004
9	N(4)-oleylcytosine arabinosideIBA 01/2021 - 08/2014
9	Tenecteplase FDA Link 07/2009 - 04/2003
8	CholesterolIBA 01/2022 - 01/2012
7	N(2)-(3-trifluoromethylphenyl)guanineIBA 04/2014 - 05/2004
7	Prasugrel Hydrochloride FDA Link 11/2013 - 03/2009
7	Heparin (Liquaemin)FDA LinkGeneric 07/2009 - 01/2003
6	TicagrelorIBA 01/2022 - 01/2010
6	eicosapentaenoic acid ethyl esterIBA 01/2022 - 01/2020
6	TroponinIBA 01/2022 - 12/2004
6	AntithrombinsIBA 04/2018 - 08/2004
5	RivaroxabanIBA 01/2022 - 09/2013
5	Lipoprotein(a)IBA 01/2022 - 08/2013
5	Tirofiban (Aggrastat)FDA Link 11/2020 - 02/2004
5	Dabigatran FDA Link 01/2018 - 09/2011
5	MB Form Creatine KinaseIBA 04/2016 - 09/2003
4	apixabanIBA 02/2022 - 08/2014
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2017
4	Monoclonal AntibodiesIBA 01/2022 - 01/2012
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 01/2013
4	HDL CholesterolIBA 01/2020 - 10/2011
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 04/2005
4	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 01/2012
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2016 - 01/2003
4	Platelet Membrane Glycoprotein IIbIBA 01/2012 - 01/2008
3	omega-Chloroacetophenone (Mace)IBA 03/2022 - 12/2019
3	C-Reactive ProteinIBA 01/2022 - 10/2018
3	Growth Differentiation Factor 15IBA 01/2021 - 10/2010
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2014
3	HDL LipoproteinsIBA 01/2020 - 08/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2007
3	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 04/2016 - 04/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2014 - 03/2009
2	ApolipoproteinsIBA 03/2022 - 11/2016
2	Lipoproteins (Lipoprotein)IBA 03/2022 - 01/2022

Therapy/Procedure

93	Therapeutics 03/2022 - 04/2003
34	Percutaneous Coronary Intervention 01/2018 - 01/2003
17	Thrombolytic Therapy 04/2011 - 01/2003
8	Secondary Prevention 01/2022 - 01/2013
7	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 07/2007
6	Drug Tapering 01/2019 - 05/2012
5	Patient Readmission 06/2015 - 02/2004
5	Stents 10/2014 - 03/2011
3	Drug-Eluting Stents 03/2011 - 06/2003